Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Bridge Biotherapeutics Presented Non-clinical Study Results for 2 IPF Candidates at the IPF Summit 2022 2022-09-02 09:41
WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility in Cranbury, New Jersey 2022-08-31 20:00
Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc. 2022-08-31 17:05
Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences 2022-08-29 21:00
NEXT-GENERATION EGFR TKI H002 FROM REDCLOUD BIO COMPLETES FIRST DOSE IN NON-SMALL CELL LUNG CANCER 2022-08-29 19:30
Sanyou Biopharmaceuticals and KangaBio established strategic collaboration to accelerate antibody drug development and innovation 2022-08-28 08:00
Ascentage Pharma Announces 2022 Interim Results 2022-08-27 00:47
First approval of Cadonilimab (PD-1/CTLA-4 bispecific) published in Drugs, a peer-reviewed medical journal 2022-08-26 20:00
Tigermed Reports 2022 Interim Result with Strong Financial Growth 2022-08-25 19:05
Alpha Biopharma Announces Completion of its EVEREST Phase II/III Clinical Study of Zorifertinib in Non-Small Cell Lung Cancer Patients with Central Nervous System Metastases 2022-08-25 10:00
MGI Wins IBO Design Gold Award for DNBelab C4 Pocket Single-Cell Lab 2022-08-24 22:05
AVELOS THERAPEUTICS ANNOUNCES $8 MILLON SERIES A FUNDING ROUND 2022-08-22 20:00
Biosion, Inc. Appoints Steven Knapp, Pharm.D. as Chief Regulatory & Quality Officer 2022-08-22 13:00
World's First CAR-T for NMOSD Treatment, IASO Biotherapeutics' Equecabtagene Autoleucel, Receives IND Approval by NMPA 2022-08-19 18:41
J INTS BIO successfully held its 1st International Advisory Board Meeting for its Novel Oral 4th Generation EGFR TKI (JIN-A02) in Vienna, Austria during WCLC 2022-08-19 16:00
Nuance Pharma Announces Clearance of IND Application for Ensifentrine Pivotal Clinical Trials for COPD in China 2022-08-19 11:24
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand for Adolescents Aged 12 Through 17 2022-08-18 21:06
Case Report of Long Term Complete Response in Hepatocellular Carcinoma to CARsgen's GPC3 CAR T Cells (CT011) Published in Frontiers in Immunology 2022-08-18 20:50
Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery 2022-08-18 20:30
WeTrade Group Inc. Ready to kick-off a Strategic Partnership with Zhixun Bio through WeTrade's SaaS platform and its the Internet of Things (IoT) 2022-08-18 20:23
1 70 71 72 73 74 220